Lakefront Biotherapeutics NV current report, Q4 FY2018

Business Context and Reporting Period

This Form 6-K filing is submitted by Galapagos NV (not Lakefront Biotherapeutics NV as indicated in the metadata) for the month of October 2018. The registrant is a foreign private issuer incorporated in Belgium, with its principal executive office in Mechelen. The filing primarily serves to incorporate by reference a press release dated October 21, 2018 (Exhibit 99.1), into the company's existing Registration Statements on Forms F-3 and S-8.

Financial Metrics

The filing text does not provide specific financial data. There are no disclosed values for revenue, profit, cash flow, margins, debt, or liquidity within this document. The content is limited to regulatory procedural information and the incorporation of an external press release.

Material Changes

No material financial changes versus prior periods are detailed in this filing. The document does not contain comparative financial statements or operational metrics to assess changes.

Guidance, Outlook, and Risks

The filing references a press release (Exhibit 99.1) but does not reproduce its content, except to explicitly exclude quotes from Dr. John McHutchison and Dr. Walid Abi-Saab from incorporation by reference. Consequently, specific guidance, management commentary, risks, contingencies, or unusual items are not described in the provided text.

Key Facts for Investor Verification

  • Company Identity: Verify that the filing pertains to Galapagos NV, not Lakefront Biotherapeutics NV.
  • Source of Information: Critical details regarding the October 21, 2018 event are located in Exhibit 99.1 (the press release), which is not included in the provided text.
  • Excluded Content: Note that quotes from Dr. John McHutchison and Dr. Walid Abi-Saab within the press release are not incorporated by reference into the registration statements.
  • Financial Data: This specific filing contains no financial numbers; investors must refer to the company's Form 20-F or the full press release for financial context.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.